HomeInsightsStock Comparison

Lincoln Pharmaceuticals Ltd vs Onesource Specialty Pharma Ltd Stock Comparison

Lincoln Pharmaceuticals Ltd vs Onesource Specialty Pharma Ltd Stock Comparison

Last Updated on: Dec 18, 2025

Key Highlights

  • The Latest Trading Price of Lincoln Pharmaceuticals Ltd is ₹ 475.2 as of 18 Dec 15:30.
  • The P/E Ratio of Lincoln Pharmaceuticals Ltd changed from 5.2 on March 2020 to 13.4 on March 2025 . This represents a CAGR of 17.09% over 6 yearsThe P/E Ratio of OneSource Specialty Pharma Ltd changed from 0 on March 2020 to 0 on March 2025 . This represents a CAGR of 0.0% over 6 years.
  • The Market Cap of Lincoln Pharmaceuticals Ltd changed from ₹ 267.6 crore on March 2020 to ₹ 1104 crore on March 2025 . This represents a CAGR of 26.66% over 6 yearsThe Market Cap of OneSource Specialty Pharma Ltd changed from ₹ 20003 crore on March 2025 to ₹ 20003 crore on March 2025 . This represents a CAGR of 0.00% over 1 years.
  • The revenue of Lincoln Pharmaceuticals Ltd for the Sep '25 is ₹ 170.6 crore as compare to the Jun '25 revenue of ₹ 169.34 crore. This represent the growth of 0.74% The revenue of OneSource Specialty Pharma Ltd for the Sep '25 is ₹ 378.8 crore as compare to the Jun '25 revenue of ₹ 332.54 crore. This represent the growth of 13.91%.
  • The ebitda of Lincoln Pharmaceuticals Ltd for the Sep '25 is ₹ 32.66 crore as compare to the Jun '25 ebitda of ₹ 39.08 crore. This represent the decline of -16.43% The ebitda of OneSource Specialty Pharma Ltd for the Sep '25 is ₹ 109.53 crore as compare to the Jun '25 ebitda of ₹ 90.88 crore. This represent the growth of 20.52%.
  • The net profit of Lincoln Pharmaceuticals Ltd changed from ₹ 19.01 crore to ₹ 19.98 crore over 10 quarters. This represents a CAGR of 2.01% The net profit of OneSource Specialty Pharma Ltd changed from ₹ -107 crore to ₹ 10.49 crore over 10 quarters. This represents a CAGR of NaN% .
  • The Dividend Payout of Lincoln Pharmaceuticals Ltd changed from 6.13 % on March 2020 to 4.38 % on March 2025 . This represents a CAGR of -5.45% over 6 yearsThe Dividend Payout of OneSource Specialty Pharma Ltd changed from 0 % on March 2020 to 0 % on March 2025 . This represents a CAGR of 0.0% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Lincoln Pharmaceuticals Ltd

  • Lincoln Pharmaceuticals Limited, promoted by Mahendra G Patel, Rajnikant G Patel and Hasmukhbhai I Patel, as a Partnership Firm in January, 1979 to manufacture pharmaceutical formulations was converted into a Public Limited Company in Jan. '95.
  • All the assets and business of the erstwhile partnership were transferred to the Company.
  • The Company is engaged in the business of manufacturing and trading of pharmaceutical products.
  • The focused area includes anti-infective, respiratory system, gynecology, cardio & CNS, anti-diabetic, anti malaria, among others. The Company, incorporated in January, 1995, was carrying on its business by getting its products manufactured on loan licence basis from 1979 to 1982.
  • It then set up its own manufacturing facilities at Naroda, Gujarat for manufacturing tablets, capsules, liquid and powder syrups and, ointments.

About OneSource Specialty Pharma Ltd

  • Onesource Specialty Pharma Limited was incorporated as a Private Limited Company, with the name and style of Inbiopro Solutions Private Limited' dated June 12, 2007, was issued by the Registrar of Companies, Karnataka at Bangalore.
  • The Company name was then changed to Stelis Biopharma Private Limited', pursuant to a Scheme of Amalgamation and a Certificate of Incorporation dated December 24, 2014, was issued by the Registrar of Companies.
  • The status of the Company was then converted from a Private Limited Company to a Public Limited Company, and renamed as Stelis Biopharma Limited' dated July 31, 2021,.
  • Subsequently, the name was changed to its present Onesource Specialty Pharma Limited' on February 13, 2024, and a fresh Certificate of Incorporation dated February 13, 2024, was issued by the Registrar of Companies, Karnataka at Bangalore.

Lincoln Pharmaceuticals Ltd News Hub

News

Lincoln Pharmaceuticals declines after weak Q2 performance

EBITDA fell by 14.86% to Rs 32.66 crore in Q2 FY26 from Rs 38.35 crore in Q2 FY25. Profit ...

Read more

13 Nov 2025 13:59

News

Lincoln Pharmaceuticals to discuss results

Lincoln Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13...

Read more

06 Nov 2025 12:35

News

Lincoln Pharmaceuticals AGM scheduled

Lincoln Pharmaceuticals announced that the 31st Annual General Meeting(AGM) of the company...

Read more

30 Aug 2025 19:04

News

Lincoln Pharmaceuticals announces board meeting date

Lincoln Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 7 ...

Read more

29 Jul 2025 10:52

News

Board of Lincoln Pharmaceuticals recommends final dividend

Lincoln Pharmaceuticals announced that the Board of Directors of the Company at its meetin...

Read more

22 May 2025 18:24

News

Lincoln Pharmaceuticals to declare Quarterly Results

Lincoln Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 22...

Read more

16 May 2025 14:05

OneSource Specialty Pharma Ltd News Hub

News

OneSource Specialty Pharma allots 23,000 equity shares under ESOP

OneSource Specialty Pharma has allotted 23,000 equity shares under ESOP on 09 December 202...

Read more

09 Dec 2025 17:17

News

OneSource Specialty Pharma schedules board meeting

OneSource Specialty Pharma will hold a meeting of the Board of Directors of the Company on...

Read more

06 Nov 2025 17:22

News

OneSource Specialty Pharma to hold AGM

OneSource Specialty Pharma announced that the 18th Annual General Meeting(AGM) of the comp...

Read more

03 Sep 2025 09:52

News

Outcome of board meeting of OneSource Specialty Pharma

The Board of OneSource Specialty Pharma at its meeting held on 04 August 2025 has given th...

Read more

05 Aug 2025 10:29

News

OneSource Specialty Pharma to hold board meeting

OneSource Specialty Pharma will hold a meeting of the Board of Directors of the Company on...

Read more

30 Jul 2025 11:14

News

OneSource collaborates with Xbrane Biopharma AB

OneSource Specialty Pharma and Xbrane Biopharma AB, a Sweden-headquartered biotechnology c...

Read more

11 Jun 2025 09:07

SWOT Analysis Of OneSource Specialty Pharma Ltd

Strength

0

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Lincoln Pharmaceuticals Ltd

Strength

3

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Lincoln Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Lincoln Pharmaceuticals Ltd and OneSource Specialty Pharma Ltd

Which company has a larger market capitalization, Lincoln Pharmaceuticals Ltd or OneSource Specialty Pharma Ltd?

Market cap of Lincoln Pharmaceuticals Ltd is 951 Cr while Market cap of OneSource Specialty Pharma Ltd is 18,899 Cr

What are the key factors driving the stock performance of Lincoln Pharmaceuticals Ltd and OneSource Specialty Pharma Ltd?

The stock performance of Lincoln Pharmaceuticals Ltd and OneSource Specialty Pharma Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Lincoln Pharmaceuticals Ltd and OneSource Specialty Pharma Ltd?

As of December 18, 2025, the Lincoln Pharmaceuticals Ltd stock price is INR ₹475.2. On the other hand, OneSource Specialty Pharma Ltd stock price is INR ₹1649.35.

How do dividend payouts of Lincoln Pharmaceuticals Ltd and OneSource Specialty Pharma Ltd compare?

To compare the dividend payouts of Lincoln Pharmaceuticals Ltd and OneSource Specialty Pharma Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions